Gainers

• Asana, Inc. ASAN rose 24.1% to $23.62 in pre-market buying and selling after the corporate reported better-than-expected outcomes for its second quarter and issued a robust gross sales steering.
• AcelRx Prescription drugs, Inc. ACRX shares rose 20.5% to $0.3485 in pre-market buying and selling after gaining round 6% on Wednesday. AcelRx Prescription drugs, final month, posted a Q2 lack of $0.06 per share.
• Revance Therapeutics, Inc. RVNC rose 18.4% to $24.66 in pre-market buying and selling as the corporate reported the FDA approval of DAXXIFY for injection, a peptide-formulated neuromodulator with long-lasting outcomes.
• Vivid Inexperienced Company BGXX rose 15.2% to $1.80 in pre-market buying and selling as the corporate reported pricing of $10.0 million non-public placement.
• Ayala Prescription drugs, Inc. AYLA shares rose 12% to $1.96 in pre-market buying and selling after gaining over 4% on Wednesday.
• Rubius Therapeutics, Inc. RUBY rose 11.8% to $0.9702 in pre-market buying and selling after declining 11% on Wednesday. Rubius Therapeutics, final month, posted a Q2 lack of $0.49 per share.
• Ampio Prescription drugs, Inc. AMPE rose 11% to $0.1040 in pre-market buying and selling.
• PhaseBio Prescription drugs, Inc. PHAS rose 10.4% to $1.17 in pre-market buying and selling. The corporate, final month, posted a wider Q2 loss.
• First Excessive-Faculty Schooling Group Co., Ltd. FHS rose 9.2% to $0.70 in pre-market buying and selling.
• ShiftPixy, Inc. PIXY rose 8.8% to $12.20 in pre-market buying and selling after declining over 4% on Wednesday.
• Heliogen, Inc. HLGN rose 8.6% to $2.40 in pre-market tradinh.
• GameStop Corp. GME rose 7.4% to $25.82 in pre-market buying and selling after the corporate reported better-than-expected earnings for its second quarter and in addition introduced a partnership with cryptocurrency trade FTX to deliver extra prospects to the digital asset house.

Don’t neglect to take a look at our premarket protection right here .

Losers

• Chembio Diagnostics, Inc. CEMI shares fell 16.9% to $0.52 in pre-market buying and selling. Chembio Diagnostics filed for potential inventory providing.
• American Eagle Outfitters, Inc. AEO shares fell 14.8% to $9.86 in pre-market buying and selling after the corporate reported worse-than-expected Q2 EPS outcomes.
• Dallasnews Corp DALN fell 14.4% to $7.18 in pre-market buying and selling. DallasNews lately introduced a particular dividend of $1.50 per share.
• Torrid Holdings Inc. CURV fell 13.4% to $4.65 in pre-market buying and selling after the corporate reported worse-than-expected Q2 EPS outcomes. The corporate additionally issued Q3 and FY22 gross sales steering beneath analyst estimates.
• Skillsoft Corp. SKIL fell 12.6% to $2.35 in pre-market buying and selling after the corporate posted downbeat quarterly gross sales and approved a $30 million share buyback.
• Troika Media Group, Inc. TRKA fell 12.3% to $0.57 in pre-market buying and selling after declining round 6% on Wednesday.
• Wayfair Inc. W fell 9.3% to $46.00 in pre-market buying and selling after the corporate reported a proposed providing of $600 million convertible senior notes.
• Grid Dynamics Holdings, Inc. GDYN fell 9.1% to $18.00 in pre-market buying and selling after the corporate priced its frequent inventory providing of about 5.71 million shares at $17.50 per share.
• HyreCar Inc. HYRE fell 8.8% to $1.25 in pre-market buying and selling. HyreCar shares gained round 8% on Wednesday after the corporate introduced it has acquired a $100 million revolving line of credit score from a premier international funding financial institution and Medalist Companions.
• DBV Applied sciences S.A. DBVT shares fell 7.6% to $2.08 in pre-market buying and selling. DBV Applied sciences reported initiation of Section 3 research (VITESSE) utilizing the modified viaskin peanut patch in peanut -allergic kids ages 4 to 7 years.
• Bilibili Inc. BILI fell 6.4% to $22.10 in pre-market buying and selling following Q2 outcomes.
• McCormick & Firm, Integrated MKC fell 6.1% to $79.83 in pre-market buying and selling. McCormick mentioned it expects third-quarter FY22 gross sales to extend about 3% year-on-year and 6% in fixed forex.